Collectively, the observed alterations in machinery controlling the chromatin status, as well as the affected expression of glucose-metabolism-related genes, may serve as an attractive explanation for the reduced CD4+ T cell proliferation rate and suppressed effector function when CD4+ T cells were co-cultured with cancer cells. The gene discussed is CD4; the disease is cancer.